MedPlus Health Services has disclosed that its subsidiary, Optival Health Solutions Private Limited, received a suspension order for a drug license pertaining to one store location in Karnataka. The order, received on March 21, 2026, impacts a store situated at Guthal Road, Mandya. The authority cited potential violations under the Drugs and Cosmetics Act. The estimated financial impact is a Potential Revenue Loss of Rs 0.37 lacs.
Operational Update Regarding Subsidiary License
MedPlus Health Services Limited is informing stakeholders about an administrative action taken against its subsidiary, Optival Health Solutions Private Limited. The subsidiary received a suspension order concerning a Drug License for one of its retail stores operating in Karnataka.
Details of the Regulatory Action
The specific store affected is located at Guthal Road, Mandya, Karnataka. The order mandates the suspension of the Drug License for a duration of three days. The formal order was received by the company’s Assistant Director, Drugs Control Administration, Mandya Circle, on March 21, 2026.
The grounds for the suspension relate to alleged violations of Rule 65 of the Drugs and Cosmetics Act, 1940, and the associated Rules of 1945. While no ongoing interim orders or communications from the authority were noted beyond the initial directive, the potential short-term financial impact has been quantified.
Quantified Impact
The company has estimated the immediate financial consequence of this temporary halt in operations. The Potential Revenue Loss resulting from the three-day closure is quantified at Rs 0.37 lacs. This event is not expected to materially affect the overall operational performance of the listed entity.
Source: BSE
